Drug Approval | December 21, 2021
Shilpa Medicare launch Prucalshil for treatment of constipation
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research
T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as the foundation for various investigational CAR-T therapies
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
_256_384.jpg)
Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants
The company plans to expand their capacity to meet the needs of pharma and biotech industries
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The company has has 10 existing labs in India
Subscribe To Our Newsletter & Stay Updated
